Market News AIOpen the app

Boston Scientific Corp is set to issue $3 billion in U.S. notes and €4.25 billion in euro notes to buy Penumbra, Inc.

New sharesRead the original at SEC EDGAR
Neutral

The bonds provide cash for Penumbra's purchase, but also add years of interest payments and a redemption cost if the deal fails. The filing gives no business results from Penumbra, so it does not change Boston Scientific's outlook by itself.

BSX · Boston Scientific Corporation

AI read · Neutral

The AI's read

The money would help cover Penumbra's cash payment, but Boston Scientific must pay interest on the new notes. The filing gives no figures showing whether Penumbra's business gains would cover those costs. If the purchase does not happen, most notes must be redeemed for 101% of their principal, plus unpaid interest.

PEN · Penumbra, Inc.

AI read · Neutral

The connection

Boston Scientific arranged funding intended for Penumbra's cash purchase price, but the filing does not say the deal has closed or changed. This financing alone does not change Penumbra's outlook.

Get alerts for BSX

Follow Boston Scientific Corporation (BSX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for BSX
Free on the App Store and Google Play, or on the web.